PTN vs PULM

Palatin Technologies, Inc. Common Stock vs Pulmatrix, Inc. — Valuation Comparison 2026

PTN

Pharmaceutical Preparations
Palatin Technologies, Inc. Common Stock
Quality
5.7
out of 10
Value Trap
33
LOW
Price
$14.02
Last close
Models
9/13
Active
VS

PULM

Pharmaceutical Preparations
Pulmatrix, Inc.
Quality
5.6
out of 10
Value Trap
24
SAFE
Price
$1.39
Last close
Models
9/13
Active

Model-by-Model Comparison

ModelType PTN Fair ValuePTN Upside PULM Fair ValuePULM Upside
Bayesian DCF Intrinsic $5.85 -58.3% $0.84 -39.7%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $27.14 +93.6% $3.25 +133.5%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for PTN vs PULM — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

PTN vs PULM — Which Stock Is More Undervalued?

PTN scores higher with a 5.7/10 quality rating vs PULM's 5.6/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Palatin Technologies, Inc. Common Stock (PTN) and Pulmatrix, Inc. (PULM) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

PTN currently trades at $14.02 with a QOC of 5.7/10, while PULM trades at $1.39 with a QOC of 5.6/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).